MAGEA3 and cancer: We previously reported on the expression of MAGE-1 and MAGE-3 in several cancers (Inoue et al, 1995), and we identified several MAGE peptides that are recognised by cytotoxic T lymphocytes (Tanaka et al, 1997; Fujie et al, 1999).